glp 1 alzheimer's GLP-1 drugs failed to slow in two big clinical trials GLP-1 and Alzheimer's Disease: Research

A thorough initial consultation to assess your health history, current medications, and appropriateness for peptide therapy Baseline investigations, including relevant blood panels, before commencing any peptide protocol Clear informed consent regarding the experimental nature of these therapies and the limitations of current evidence Sourcing from reputable, TGA-registered compounding pharmacies only Regular review appointments to monitor for any adverse effects and reassess ongoing appropriateness An honest conversation about alternatives --- including proven regenerative therapies such as PRP, physiotherapy, and targeted nutrition --- which may complement or replace peptide use Questions to Ask Your Practitioner If you are thinking about peptide therapy, the following questions will assist in guiding an informed discussion

Zepbound (tirzepatide) Zepbound is a GLP-1 agonist with the active ingredient tirzepatide

a Canadian collegiate athlete received a four-year sanction in 2025 for use of TB-500 and BPC-157

Wegovy pill dosing frequency The Wegovy oral formulation follows the same once-daily rule